Overview of the 2017 US Food and Drug Administration Circulatory System Devices Panel meeting on the Sentinel Cerebral Protection System

American Heart Journal

Volumn 192, Issue , 2017, Pages 113-119

  Rogers, Toby ^a   Alraies, M Chadi ^a   Torguson, Rebecca ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL INJURY; BRACHIAL ARTERY; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONFERENCE PAPER; DEVICE SAFETY; EMBOLIC PROTECTION DEVICE; EMBOLIC PROTECTION FILTER; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; INTENTION TO TREAT ANALYSIS; PERCUTANEOUS AORTIC VALVE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; DEVICE APPROVAL; EQUIPMENT DESIGN; HEART ASSIST DEVICE; PROSTHESES AND ORTHOSES; STANDARDS; UNITED STATES; VASCULAR ACCESS DEVICE;

DEVICE APPROVAL; EQUIPMENT DESIGN; HEART-ASSIST DEVICES; HUMANS; PROSTHESES AND IMPLANTS; UNITED STATES; VASCULAR ACCESS DEVICES;

EID: 85027895415     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2017.06.007     Document Type: Conference Paper

References (7)

1. Smith, C.R., Leon, M.B., Mack, M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364 (2011), 2187–2198.
2. De novo classification process (evaluation of automatic class III designation). Draft guidance for industry and Food and Drug Administration staff. https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidaceDocuments/UCM273903.pdf [Accessed 02/27/2017].
3. Kapadia, S.R., Kodali, S., Makkar, R., et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol 69 (2017), 367–377.
4. Kappetein, A.P., Head, S.J., Genereux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 145 (2013), 6–23.
5. Haussig, S., Mangner, N., Dwyer, M.G., et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA 316 (2016), 592–601.
6. Van Mieghem, N.M., van Gils, L., Ahmad, H., et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention 12 (2016), 499–507.
7. Lansky, A.J., Messe, S.R., Brickman, A.M., et al. Proposed standardized neurological endpoints for cardiovascular clinical trials: an Academic Research Consortium initiative. J Am Coll Cardiol 69 (2017), 679–691.